SOLENO THERAPEUT. DL-001 (6XC) — Cash Flow Reinvestment Rate

Latest as of December 2025: 2.57x

SOLENO THERAPEUT. DL-001 (6XC) has a Cash Flow Reinvestment Rate of 2.57x as of December 2025, reinvesting €125.36 Million (capex €58.00K plus investments €-125.30 Million) from operating cash flow of €48.70 Million. Explore SOLENO THERAPEUT. DL-001 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

2.57x
(Capex + Investments) / Operating CF

Total Reinvested

€125.36 Million
Capex + Investments

Operating Cash Flow

€48.70 Million
EUR

Capital Expenditures

€58.00K
EUR

SOLENO THERAPEUT. DL-001 Cash Flow Reinvestment Rate (2025–2025)

Historical reinvestment intensity for SOLENO THERAPEUT. DL-001 across 1 annual periods. Also explore 6XC current and non-current assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for SOLENO THERAPEUT. DL-001 (2025–2025)

Year-by-year capital reinvestment analysis for SOLENO THERAPEUT. DL-001. For live market cap and broader valuation context, see 6XC company net worth.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 4.31x €201.78 Million €46.80 Million €73.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow